Flavopiridol Protects against Fungal Keratitis due to Aspergillus fumigatus by Alleviating Inflammation through the Promotion of Autophagy

Fungal keratitis is a serious infectious keratopathy related to Fungal virulence and excessive inflammatory responses. Autophagy exhibits a potent ability to resolve inflammation during fungal Infection. This study aimed to investigate the protective function of flavopiridol in Aspergillus fumigatus keratitis and explore its effects on Autophagy. In our study, the corneas of the Fungal keratitis mouse model were treated with 5 μM flavopiridol. In vitro, RAW 264.7 cells were pretreated with 200 nM flavopiridol before Fungal stimulation. A. fumigatus was incubated with flavopiridol, and the Antifungal activity of flavopiridol was detected. Our results indicated that flavopiridol treatment notably reduced clinical scores as well as cytokines expression of infected corneas. In infected RAW 264.7 cells, flavopiridol treatment inhibited IL-1β, IL-6, and TNF-α expression but promoted IL-10 expression. Transmission electron microscopy (TEM) images showed that more autolysosomes were present in infected corneas and RAW 264.7 cells after flavopiridol treatment. Flavopiridol treatment notably upregulated the protein expression of LC3, Beclin-1, and Atg-7. 3-Methyladenine (3-MA, an inhibitor of Autophagy) pretreatment counteracted the cytokine regulation induced by flavopiridol. Moreover, flavopiridol promoted the phagocytosis of RAW 264.7 cells. Flavopiridol also exhibited Antifungal activity by restricting Fungal growth and limiting Fungal biofilm formation and conidial adhesion. In conclusion, flavopiridol significantly alleviated the inflammation of Fungal keratitis by activating Autophagy. In addition, flavopiridol promoted the phagocytosis of RAW 264.7 cells and exhibited Antifungal function, indicating the potential therapeutic role of flavopiridol in Fungal keratitis.

Aspergillus fumigatus; autophagy; flavopiridol; fungal keratitis; inflammation.